Your browser does not support the NLM PubReader view.

Go to this page to see a list of supporting browsers.

Hypotension after induction of anesthesia with remimazolam or etomidate: a non-inferiority randomized controlled trial in patients undergoing coronary artery bypass grafting

Article information

Korean J Anesthesiol. 2025;.kja.24537.e1
Publication date (electronic) : 2025 April 15
doi : https://doi.org/10.4097/kja.24537.e1
Jeong-Jin Min1, Eun Jung Oh2, Hyun Ji Hwang1, Sungwoo Jo1, Hyunsung Cho1, Chungsu Kim1, Jong-Hwan Lee1
1Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2Department of Anesthesiology and Pain Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea

Korean Journal of Anesthesiology 2025;78(2):139-147

DOI: https://doi.org/10.4097/kja.24537

­

The article by Min JJ, et al. entitled, “Hypotension after induction of anesthesia with remimazolam or etomidate: a non-inferiority randomized controlled trial in patients undergoing coronary artery bypass grafting” (Korean J Anesthesiol 2025;78(2):139-147) was published incorrectly in the author’s affiliation.

­

Before correction:

Department of Anesthesiology and Pain Medicine, 1Samsung Medical Center, Sungkyunkwan University School of Medicine, 2Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Seoul, Korea

­

The correct information is found below:

Department of Anesthesiology and Pain Medicine, 1Samsung Medical Center, Sungkyunkwan University School of Medicine, 2Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea

­

The authors would like to apologize for any inconvenience caused.

Article information Continued

© The Korean Society of Anesthesiologists, 2025

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.